chromosome enumeration probe 17 (CEP17)
Jump to navigation
Jump to search
Indications
- used in conjunction with HER2 amplification in evaluation of breast cancer
Methods
More general terms
Additional terms
Component of
References
- ↑ Hanna WM, Ruschoff J, Bilous M et al HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity. Modern Pathology (2014) 27, 4-18 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23807776 Free Article <Internet> http://www.nature.com/modpathol/journal/v27/n1/full/modpathol2013103a.html